Clincosm LogoSign in Get a demo

Ovarian Cancer

Showing NaN - NaN of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • Anchorage, Alaska
  • +55 more
Jul 25, 2022

Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer Trial in Canada, Poland, United States

Recruiting
  • Ovarian Granulosa-Stromal Tumor
  • +2 more
  • Los Angeles, California
  • +20 more
Jul 13, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (Microdevice)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Microdevice
  • Boston, Massachusetts
  • +1 more
Jul 12, 2022

Ovarian Cancer, Breast Cancer, Lung Cancer Trial in Boston, Omaha, Columbus (Digital Health Coaching Program, Fitbit)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Digital Health Coaching Program
  • Fitbit
  • Boston, Massachusetts
  • +2 more
Jul 13, 2022

Ovarian Cancer Trial in Boston (drug, biological, procedure)

Recruiting
  • Ovarian Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 11, 2022

Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, Ovarian Cancer Trial in United States (mRNA-2416, Durvalumab)

Terminated
  • Relapsed/Refractory Solid Tumor Malignancies or Lymphoma
  • Ovarian Cancer
  • mRNA-2416
  • Durvalumab
  • Aurora, Colorado
  • +8 more
Jul 7, 2022

Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +27 more
Jun 27, 2022

Ovarian Cancer, Fatigue, Coping Behavior Trial in Boston, Philadelphia (Enhanced Usual Care (EOC), REVITALIZE ACT Intervention)

Active, not recruiting
  • Ovarian Cancer
  • +3 more
  • Enhanced Usual Care (EOC)
  • REVITALIZE ACT Intervention
  • Boston, Massachusetts
  • +1 more
Jun 13, 2022

Ovarian Cancer Trial in Boston (Fitness Tracker, Social Incentive (Way to Health))

Completed
Has Results
  • Ovarian Cancer
  • Fitness Tracker
  • Social Incentive (Way to Health)
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 13, 2022

ER+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer Trial in United States (BLU-222, Carboplatin, Ribociclib)

Recruiting
  • ER+ Breast Cancer
  • +8 more
  • Sarasota, Florida
  • +3 more
Jun 8, 2022

Ovarian Cancer, Ovarian Carcinoma, Ovarian Cancer Stage IV Trial in Boston (Exercise, Attention Control)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Exercise
  • Attention Control
  • Boston, Massachusetts
    Dana Farber Cancer Institute
May 4, 2022

Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,

Recruiting
  • Small Cell Lung Cancer
  • +4 more
  • PF-07104091 monotherapy dose escalation
  • +8 more
  • Clive, Iowa
  • +22 more
Apr 26, 2022

Solid Tumors, Colorectal Cancer, Breast Cancer Trial in Canada, United States (LY2880070, Gemcitabine)

Completed
  • Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Ovarian Cancer Trial in United States (AVB-S6-500, Paclitaxel (Pac), Pegylated liposomal doxorubicin (PLD))

Active, not recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +15 more
Feb 16, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Oral rucaparib)

Completed
Has Results
  • Ovarian Cancer
  • +3 more
  • Oral rucaparib
  • Anchorage, Alaska
  • +74 more
Jan 31, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (GM-CSF, Dendritic Cell/Tumor Fusion Vaccine,

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +3 more
Jan 25, 2022

Ovarian Cancer Trial in Boston, Copenhagen (Niraparib, Bevacizumab)

Completed
  • Ovarian Cancer
  • Boston, Massachusetts
  • +1 more
Jan 7, 2022

Ovarian Cancer Trial in Worldwide (Prexasertib)

Completed
Has Results
  • Ovarian Cancer
  • Tucson, Arizona
  • +45 more
Sep 28, 2021

Ovarian Tumors, Ovarian Cancer Trial in Canada, United States (Niraparib)

Completed
Has Results
  • Ovarian Neoplasms
  • Ovarian Cancer
  • Chandler, Arizona
  • +54 more
Sep 24, 2021

Breast Cancer, Ovarian Cancer, Colorectal Cancer Trial in United States (Durvalumab, Tremelimumab)

Completed
Has Results
  • Breast Cancer
  • +4 more
  • New Haven, Connecticut
  • +5 more
Jul 13, 2021